Turn Therapeutics Inc. Common Stock (TTRX) Stock Price

TTRXStock
$9.84
Market Cap$298.82M
P/E
PEG Ratio
Div yield
Beta0.70

TTRX Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)181.80%
Price vs S&P 500 (4W)9.77%
VGM Score90.81

TTRX Earnings Surprise History

QuarterReport dateEPS estimateEPS actualSurprise
Q2 2026-$0.02-$0.20-900.00%(-$0.18)
Q1 2026-$0.02-$0.04-102.00%(-$0.02)

TTRX Analyst Recommendations

May 2026
Jun 2026
Jul 2026
Aug 2026
4.13
4.14
4.14
4.25

Industry Peers — Pharmaceuticals(570)

SymbolValue ScoreGrowth ScoreMomentum ScorePrice
TTRXTurn Therapeutics Inc. Common Stock
A$9.84
LLYEli Lilly & Co.DBC$1174.61
JNJJohnson & JohnsonDCB$268.04
ABBVABBVIE INC.DCB$255.48
MRKMerck & Co., Inc.DCB$148.35
NVSNovartis AGCCC$153.81
AZNAstraZeneca PLCCBC$162.70
NVONovo-Nordisk A/SBCC$45.61
ABTAbbott LaboratoriesCCC$112.47
PFEPfizer Inc.CDB$27.96
VRTXVertex Pharmaceuticals IncDCB$541.69

About Turn Therapeutics Inc. Common Stock

Turn Therapeutics is a clinical-stage biotechnology company developing treatments for dermatology, wound care, and infectious diseases. The company's proprietary PermaFusion platform enhances drug stability and bioavailability, enabling lower doses and reduced side effects. Its lead programs target moderate to severe eczema and onychomycosis.